ZBIO

Zenas BioPharma

139 hedge funds and large institutions have $1.1B invested in Zenas BioPharma in 2026 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 57 increasing their positions, 17 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
139
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.48M
Puts
$2.71M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$178M
SOCM
2
SR One Capital Management
Pennsylvania
$98.5M
NMC
3
NEA Management Company
Maryland
$78.7M
ES
4
Enavate Sciences
California
$76.6M
Federated Hermes
5
Federated Hermes
Pennsylvania
$61.1M
PCH
6
Polar Capital Holdings
United Kingdom
$49.8M
Capital International Investors
7
Capital International Investors
California
$47.6M
FFM
8
Fairmount Funds Management
Pennsylvania
$46.1M
BlackRock
9
BlackRock
New York
$39.8M
NA
10
NVP Associates
California
$35.9M
AllianceBernstein
11
AllianceBernstein
Tennessee
$32.6M
State Street
12
State Street
Massachusetts
$28.8M
Wellington Management Group
13
Wellington Management Group
Massachusetts
$24.4M
VCM
14
Vanguard Capital Management
Pennsylvania
$24.3M
SCM
15
Silverarc Capital Management
Massachusetts
$22.2M
EC
16
EcoR1 Capital
California
$15.4M
Balyasny Asset Management
17
Balyasny Asset Management
Illinois
$13M
ACH
18
ArrowMark Colorado Holdings
Colorado
$12.9M
Geode Capital Management
19
Geode Capital Management
Massachusetts
$12.8M
PBPIA
20
Pivotal bioVenture Partners Investment Advisor
California
$11.6M
WP
21
Woodline Partners
California
$11.5M
GPP
22
Great Point Partners
Connecticut
$10.2M
RSCM
23
Rock Springs Capital Management
Maryland
$9.82M
Marshall Wace
24
Marshall Wace
United Kingdom
$9.81M
Millennium Management
25
Millennium Management
New York
$9.32M